Manipulation of gene expression by an ecdysone-inducible gene switch in tumor xenografts

BMC Biotechnology

Larry R Karns¹  Anne Kisielewski³  Kathryn M Gulding²  Dan Theodorescu² 

[1] Upstate Biotechnology Inc., Charlottesville, Virginia

[2] Department of Molecular Physiology and Biological Physics University of Virginia, Charlottesville, Virginia, USA

[3] Present address: Upstate Biotechnology Inc., Charlottesville, Virginia, USA

关键词: Tumor Cells;    Transcription Factors;    Mice;    Gene Expression Regulation. Ligands;    Ecdysone;   

Others  :  1160994
DOI  :  10.1186/1472-6750-1-11

 received in 2001-09-06, accepted in 2001-12-18,  发布年份 2001

【 授权许可】

   
2001 Karns et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 参考文献 】

• [1]Gingrich JR, Roder J: Inducible gene expression in the nervous system of transgenic mice. Annu Rev Neurosci 1998, 21:377-405.
• [2]Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H: Transcriptional activation by tetracyclines in mammalian cells. Science 1995, 268:1766-1769.
• [3]Saez E, No D, West A, Evans RM: Inducible gene expression in mammalian cells and transgenic mice. Curr Opin Biotechnol 1997, 8:608-616.
• [4]Harvey DM, Caskey CT: Inducible control of gene expression: prospects for gene therapy. Curr Opin Chem Biol 1998, 2:512-518.
• [5]Senner V, Sturm A, Hoess N, Wassmann H, Paulus W: In vivo glioma model enabling regulated gene expression. Acta Neuropathol (Berl) 2000, 99:603-608.
• [6]Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A 1994, 91:9302-9306.
• [7]No D, Yao TP, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 1996, 93:3346-3351.
• [8]Yam JW, Chan KW, Hsiao WL: Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B. Oncogene 2001, 20:58-68.
• [9]Hoppe UC, Marban E, Johns DC: Adenovirus-mediated inducible gene expression in vivo by a hybrid ecdysone receptor. Mol Ther 2000, 1:159-164.
• [10]Saez E, Nelson MC, Eshelman B, Banayo E, Koder A, Cho GJ, Evans RM: Identification of ligands and coligands for the ecdysone-regulated gene switch. Proc Natl Acad Sci U S A 2000, 97:14512-14517.
• [11]Dhadialla TS, Carlson GR, Le DP: New insecticides with ecdysteroidal and juvenile hormone activity. Annu Rev Entomol 1998, 43:545-569.
• [12]Eto M, Harada M, Tamada K, Tokuda N, Koikawa Y, Nakamura M, Nomoto K, Naito S: Antitumor activity of interleukin-12 against murine bladder cancer. J Urol 2000, 163:1549-1552.
• [13]Chin JL, Kadhim SA, Batislam E, Karlik SJ, Garcia BM, Nickel JC, Morales A: Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer. J Urol 1996, 156:1189-1193.
• [14]Palli SR: Novel ecdysome receptor-based inducible gene expression systems. Molecular Therapy 2001., 3
• [15]Leclerc GM, Boockfor FR, Faught WJ, Frawley LS: Development of a destabilized firefly luciferase enzyme for measurement of gene expression. Biotechniques 2000, 29:590-598.
• [16]Wing KD: RH a nonsteroidal ecdysone agonist: effects on a Drosophila cell line. Science 5849, 241:467-469.
• [17]Coralli C, Cemazar M, Kanthou C, Tozer GM, Dachs GU: Limitations of the reporter green fluorescent protein under simulated tumor conditions. Cancer Res 2001, 61:4784-4790.
• [18]Bittner B, Thelly T, Isel H, Mountfield RJ: The impact of co-solvents and the composition of experimental formulations on the pump rate of the ALZET osmotic pump. Int J Pharm 2000, 205:195-198.
• [19]Farquhar D, Cherif A, Bakina E, Nelson JA: Intensely potent doxorubicin analogues: structure-activity relationship. J Med Chem 1998, 41:965-972.